Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Stock Based Compensation: €0.0 Mil (TTM As of Dec. 2025)


FRA:JIL Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
81 GF Score
Price €0.27
GF Value €0.18
! 5 Warning Signs
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Stock Based Compensation?

Jilin Province Huinan Changlong Bio-pharmacy Co FRA:JIL +5.56% 81 Stock Based Compensation is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:JIL with a GF Score™ of 81/100 and a GF Value™ of €0.18. The stock has 5 warning signs investors should review.

Jilin Province Huinan Changlong Bio-pharmacy Co's Stock Based Compensation for the six months ended in Dec. 2025 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Jilin Province Huinan Changlong Bio-pharmacy Co Stock Based Compensation Related Terms

Jilin Province Huinan Changlong Bio-pharmacy Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jilin Province Huinan Changlong Bio-pharmacy Co Stock Based Compensation Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Jilin Province Huinan Changlong Bio-pharmacy Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:JIL
81GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

What does a Stock Based Compensation of €0.0 Mil mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) has a Stock Based Compensation of €0.0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Stock Based Compensation too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Stock Based Compensation is €0.0 Mil. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Stock Based Compensation compare to ZTS and UTHR?
Jilin Province Huinan Changlong Bio-pharmacy Co's Stock Based Compensation of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. Jilin Province Huinan Changlong Bio-pharmacy Co's current Stock Based Compensation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) has a current Stock Based Compensation of €0.0 Mil. The stock's GF Value™ is €0.18, compared to a current price of €0.27 — trading 47.8% above its estimated fair value. The current Stock Based Compensation is €0.0 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL), the current Stock Based Compensation is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of €0.27 is trading 47.8% above its estimated GF Value™ of €0.18.

Key valuation signals for FRA:JIL:

  • Stock Based Compensation: €0.0 Mil
  • GF Value™: €0.18 vs. price of €0.27 (47.8% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges 08049:Hong Kong
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score

Get the complete analysis for FRA:JIL

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.18
GF Value